Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country
- PMID: 38414749
- PMCID: PMC10898851
- DOI: 10.3389/fonc.2024.1329729
Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country
Abstract
Introduction: Patients with optic pathway gliomas (OPG) have good survival rates although their long-term quality of life can be affected by the tumor or treatment-related morbidity. This retrospective study sought to describe the clinical presentation and outcomes of children with OPG at a tertiary center in Mexico.
Methods: Consecutive patients <18 years-of-age with newly diagnosed OPG between January 2002 and December 2020 at the Hospital Civil de Guadalajara Dr. Juan I. Menchaca in Guadalajara, Mexico were included.
Results: Thirty patients were identified with a median age of six years. The most frequent clinical manifestations were loss of visual acuity (40%) and headaches (23%). Neurofibromatosis-1 was found in 23.3% of the patients. Surgery, either biopsy or resection, was done in 20 of 30 patients. Two patients died shortly after initial surgery. The 5-year event-free survival (EFS) was 79.3% ± 10.8% and the 5-year overall survival was 89.5% ± 6.9%. Lower EFS was associated with age less than 3 years, intracranial hypertension at presentation, and diencephalic syndrome. Patients who received surgery as first-line treatment had a 3.1 times greater risk of achieving a performance score of less than 90 points at 6 months after diagnosis (p=0.006). Of 10 patients with vision testing, 5 had improvement in visual acuity, 4 had no changes, and one patient showed worsening.
Conclusion: Our data suggests that favorable outcomes can be achieved with OPG in low- and middle-income countries, although a high rate of surgical complications was described leading to a lower overall survival. These data can be used prospectively to optimize treatment at this institute and other middle-income countries through a comprehensive, multidisciplinary approach.
Keywords: global oncology; low-and middle-income countries; low-grade glioma; optic pathway glioma; visual acuity.
Copyright © 2024 Ramírez-Melo, Moreira, Orozco-Alvarado, Sánchez-Zubieta and Navarro-Martín del Campo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1.Front Surg. 2022 May 3;9:886697. doi: 10.3389/fsurg.2022.886697. eCollection 2022. Front Surg. 2022. PMID: 35592129 Free PMC article.
-
Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.Neuropediatrics. 1994 Dec;25(6):295-300. doi: 10.1055/s-2008-1073043. Neuropediatrics. 1994. PMID: 7770126
-
Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.Br J Ophthalmol. 2018 Oct;102(10):1367-1371. doi: 10.1136/bjophthalmol-2017-311305. Epub 2018 Jan 17. Br J Ophthalmol. 2018. PMID: 29343527 Clinical Trial.
-
Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.Anticancer Res. 2016 Aug;36(8):4095-121. Anticancer Res. 2016. PMID: 27466519 Review.
-
Vision Outcomes for Pediatric Patients With Optic Pathway Gliomas Associated With Neurofibromatosis Type I: A Systematic Review of the Clinical Evidence.J Pediatr Hematol Oncol. 2021 May 1;43(4):135-143. doi: 10.1097/MPH.0000000000002060. J Pediatr Hematol Oncol. 2021. PMID: 33480655
Cited by
-
Resources for the practice of pediatric neuro-oncology in Mexico: a cross-sectional evaluation.Front Oncol. 2024 Jun 21;14:1330705. doi: 10.3389/fonc.2024.1330705. eCollection 2024. Front Oncol. 2024. PMID: 38974245 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials